Annual Cash & Cash Equivalents
$1.93 B
-$980.00 M-33.71%
December 31, 2024
Summary
- As of February 20, 2025, MRNA annual cash & cash equivalents is $1.93 billion, with the most recent change of -$980.00 million (-33.71%) on December 31, 2024.
- During the last 3 years, MRNA annual cash & cash equivalents has fallen by -$4.92 billion (-71.86%).
- MRNA annual cash & cash equivalents is now -71.86% below its all-time high of $6.85 billion, reached on December 31, 2021.
Performance
MRNA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.93 B
+$283.00 M+17.21%
December 31, 2024
Summary
- As of February 20, 2025, MRNA quarterly cash and cash equivalents is $1.93 billion, with the most recent change of +$283.00 million (+17.21%) on December 31, 2024.
- Over the past year, MRNA quarterly cash and cash equivalents has dropped by -$980.00 million (-33.71%).
- MRNA quarterly cash and cash equivalents is now -71.86% below its all-time high of $6.85 billion, reached on December 31, 2021.
Performance
MRNA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MRNA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.7% | -33.7% |
| 3 y3 years | -71.9% | -33.7% |
| 5 y5 years | +717.0% | -33.7% |
MRNA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.9% | at low | -71.9% | +17.2% |
| 5 y | 5-year | -71.9% | +717.0% | -71.9% | +717.0% |
| alltime | all time | -71.9% | >+9999.0% | -71.9% | >+9999.0% |
Moderna Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.93 B(-33.7%) | $1.93 B(+17.2%) |
| Sep 2024 | - | $1.64 B(-33.7%) |
| Jun 2024 | - | $2.48 B(+20.8%) |
| Mar 2024 | - | $2.05 B(-29.4%) |
| Dec 2023 | $2.91 B(-9.3%) | $2.91 B(-0.9%) |
| Sep 2023 | - | $2.93 B(-22.9%) |
| Jun 2023 | - | $3.80 B(+10.5%) |
| Mar 2023 | - | $3.44 B(+7.4%) |
| Dec 2022 | $3.21 B(-53.2%) | $3.21 B(+5.9%) |
| Sep 2022 | - | $3.03 B(+5.4%) |
| Jun 2022 | - | $2.87 B(-43.1%) |
| Mar 2022 | - | $5.05 B(-26.3%) |
| Dec 2021 | $6.85 B(+161.0%) | $6.85 B(+23.4%) |
| Sep 2021 | - | $5.55 B(-0.9%) |
| Jun 2021 | - | $5.60 B(+3.0%) |
| Mar 2021 | - | $5.44 B(+107.4%) |
| Dec 2020 | $2.62 B(+1012.4%) | $2.62 B(+74.3%) |
| Sep 2020 | - | $1.51 B(-14.5%) |
| Jun 2020 | - | $1.76 B(+349.7%) |
| Mar 2020 | - | $391.72 M(+66.1%) |
| Dec 2019 | $235.88 M(-64.2%) | $235.88 M(+35.8%) |
| Sep 2019 | - | $173.71 M(+14.6%) |
| Jun 2019 | - | $151.62 M(-69.9%) |
| Mar 2019 | - | $502.93 M(-23.6%) |
| Dec 2018 | $658.36 M(+388.2%) | $658.36 M(+294.1%) |
| Sep 2018 | - | $167.06 M(+23.9%) |
| Dec 2017 | $134.86 M(+169.3%) | $134.86 M(>+9900.0%) |
| Sep 2017 | - | $8700.00(-96.7%) |
| Jun 2017 | - | $263.90 K(+22.0%) |
| Mar 2017 | - | $216.40 K(+105.5%) |
| Dec 2016 | $50.08 M(+6953.5%) | - |
| Dec 2016 | - | $105.30 K(+31.6%) |
| Sep 2016 | - | $80.00 K(-75.1%) |
| Jun 2016 | - | $321.00 K(+4.6%) |
| Mar 2016 | - | $307.00 K(-56.8%) |
| Dec 2015 | $710.00 K(-61.1%) | $710.00 K(-45.9%) |
| Sep 2015 | - | $1.31 M(+80.9%) |
| Jun 2015 | - | $726.00 K(-37.6%) |
| Mar 2015 | - | $1.16 M(-36.2%) |
| Dec 2014 | $1.82 M(+100.7%) | $1.82 M(-43.1%) |
| Sep 2014 | - | $3.20 M(-25.8%) |
| Jun 2014 | - | $4.32 M(-21.8%) |
| Mar 2014 | - | $5.52 M(+507.3%) |
| Dec 2013 | $909.00 K(+320.8%) | $909.00 K(+106.1%) |
| Sep 2013 | - | $441.00 K(+354.6%) |
| Jun 2013 | - | $97.00 K(-2.0%) |
| Mar 2013 | - | $99.00 K(-54.2%) |
| Dec 2012 | $216.00 K(-77.9%) | $216.00 K(-47.7%) |
| Sep 2012 | - | $413.00 K(+330.2%) |
| Jun 2012 | - | $96.00 K(-78.0%) |
| Mar 2012 | - | $437.00 K(-55.2%) |
| Dec 2011 | $976.00 K(-8.4%) | $976.00 K(-6.5%) |
| Sep 2011 | - | $1.04 M(-77.8%) |
| Jun 2011 | - | $4.71 M(+318.6%) |
| Mar 2011 | - | $1.12 M(+5.4%) |
| Dec 2010 | $1.07 M(+42.5%) | $1.07 M(+42.5%) |
| Sep 2010 | - | $748.00 K(-30.4%) |
| Jun 2010 | - | $1.07 M(-59.2%) |
| Mar 2010 | - | $2.63 M(+251.6%) |
| Dec 2009 | $748.00 K | $748.00 K(-78.2%) |
| Sep 2009 | - | $3.43 M(-56.7%) |
| Jun 2009 | - | $7.93 M(+43.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $5.53 M(+410.3%) |
| Dec 2008 | $1.08 M(-96.1%) | $1.08 M(-87.6%) |
| Sep 2008 | - | $8.72 M(-47.5%) |
| Jun 2008 | - | $16.61 M(+5.6%) |
| Mar 2008 | - | $15.73 M(-43.2%) |
| Dec 2007 | $27.70 M(-2.7%) | $27.70 M(-32.9%) |
| Sep 2007 | - | $41.30 M(-22.1%) |
| Jun 2007 | - | $53.04 M(+6.0%) |
| Mar 2007 | - | $50.05 M(+75.7%) |
| Dec 2006 | $28.48 M(+6.4%) | $28.48 M(+35.1%) |
| Sep 2006 | - | $21.08 M(-21.6%) |
| Jun 2006 | - | $26.87 M(+26.4%) |
| Mar 2006 | - | $21.25 M(-20.6%) |
| Dec 2005 | $26.77 M(+3.8%) | $26.77 M(+68.2%) |
| Sep 2005 | - | $15.91 M(+43.6%) |
| Jun 2005 | - | $11.08 M(-40.2%) |
| Mar 2005 | - | $18.52 M(-28.2%) |
| Dec 2004 | $25.80 M(+53.6%) | $25.80 M(+90.5%) |
| Sep 2004 | - | $13.54 M(-16.8%) |
| Jun 2004 | - | $16.28 M(+45.5%) |
| Mar 2004 | - | $11.19 M(-33.4%) |
| Dec 2003 | $16.79 M(+86.1%) | $16.79 M(-27.4%) |
| Sep 2003 | - | $23.13 M(+39.5%) |
| Jun 2003 | - | $16.58 M(-1.8%) |
| Mar 2003 | - | $16.88 M(+87.1%) |
| Dec 2002 | $9.02 M(-23.3%) | $9.02 M(-36.1%) |
| Sep 2002 | - | $14.11 M(-24.5%) |
| Jun 2002 | - | $18.69 M(+5.9%) |
| Mar 2002 | - | $17.65 M(+50.1%) |
| Dec 2001 | $11.76 M(+88.0%) | $11.76 M(+64.5%) |
| Sep 2001 | - | $7.15 M(-5.9%) |
| Jun 2001 | - | $7.60 M(-12.9%) |
| Mar 2001 | - | $8.73 M(+39.5%) |
| Dec 2000 | $6.26 M(-41.5%) | $6.26 M(-20.8%) |
| Sep 2000 | - | $7.90 M(-18.2%) |
| Jun 2000 | - | $9.65 M(-9.9%) |
| Mar 2000 | - | $10.72 M(+0.2%) |
| Dec 1999 | $10.70 M(-54.5%) | $10.70 M(-40.6%) |
| Sep 1999 | - | $18.00 M(-11.8%) |
| Jun 1999 | - | $20.40 M(-8.5%) |
| Mar 1999 | - | $22.30 M(-5.1%) |
| Dec 1998 | $23.50 M(-7.1%) | $23.50 M(-3.3%) |
| Sep 1998 | - | $24.30 M(-0.8%) |
| Jun 1998 | - | $24.50 M(+18.4%) |
| Mar 1998 | - | $20.70 M(-18.2%) |
| Dec 1997 | $25.30 M(+462.2%) | $25.30 M(-3.4%) |
| Sep 1997 | - | $26.20 M(+3.6%) |
| Jun 1997 | - | $25.30 M(+8.6%) |
| Mar 1997 | - | $23.30 M(+1692.3%) |
| Dec 1996 | $4.50 M(+12.5%) | - |
| Sep 1996 | - | $1.30 M(-67.5%) |
| Jun 1996 | $4.00 M(0.0%) | $4.00 M(+1233.3%) |
| Mar 1996 | - | $300.00 K(-25.0%) |
| Dec 1995 | - | $400.00 K(-42.9%) |
| Sep 1995 | - | $700.00 K(-82.5%) |
| Jun 1995 | $4.00 M(+25.0%) | $4.00 M(+110.5%) |
| Mar 1995 | - | $1.90 M(-5.0%) |
| Dec 1994 | - | $2.00 M(-48.7%) |
| Sep 1994 | - | $3.90 M(+21.9%) |
| Jun 1994 | $3.20 M | $3.20 M(0.0%) |
| Mar 1994 | - | $3.20 M(-5.9%) |
| Dec 1993 | - | $3.40 M(+580.0%) |
| Sep 1993 | - | $500.00 K |
FAQ
- What is Moderna annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Moderna?
- What is Moderna annual cash & cash equivalents year-on-year change?
- What is Moderna quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Moderna?
- What is Moderna quarterly cash and cash equivalents year-on-year change?
What is Moderna annual cash & cash equivalents?
The current annual cash & cash equivalents of MRNA is $1.93 B
What is the all time high annual cash & cash equivalents for Moderna?
Moderna all-time high annual cash & cash equivalents is $6.85 B
What is Moderna annual cash & cash equivalents year-on-year change?
Over the past year, MRNA annual cash & cash equivalents has changed by -$980.00 M (-33.71%)
What is Moderna quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MRNA is $1.93 B
What is the all time high quarterly cash and cash equivalents for Moderna?
Moderna all-time high quarterly cash and cash equivalents is $6.85 B
What is Moderna quarterly cash and cash equivalents year-on-year change?
Over the past year, MRNA quarterly cash and cash equivalents has changed by -$980.00 M (-33.71%)